Mutations identified in MKKS result in a shortened chaperone protein and are present in 5%–7% of BBS cases; however, the links between MKKS, its eventual target proteins, and the BBS clinical traits are largely unknown. Here, MKKS is linked to Bardet-Biedl syndrome.